|
"park j w"的相关文件
显示项目 21-30 / 32 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2021-06-25T08:49:25Z |
Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe
|
Lee S.U.; Yoon S.M.; Cheng J.C.-H.; Kim T.H.; Kim B.H.; Park J.-H.; Jung J.; Tsai C.-L.; YUN CHIANG; Park J.-W. |
| 臺大學術典藏 |
2021-05-21T07:17:41Z |
Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe
|
Lee S.U.; Yoon S.M.; Cheng J.C.-H.; Kim T.H.; Kim B.H.; Park J.-H.; Jung J.; CHIAO-LING TSAI; Chiang Y.; Park J.-W. |
| 國立成功大學 |
2021 |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo, B.-Y.;Cheng, A.-L.;Ren, Z.;Kim, T.-Y.;Pan, H.;Rau, K.-M.;Choi, H.J.;Park, J.-W.;Kim, J.H.;Yen, C.J.;Lim, H.Y.;Zhou, D.;Straub, J.;Scheele, J.;Berghoff, K.;Qin, S. |
| 臺大學術典藏 |
2020-08-11T08:36:43Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.;Cheng A.-L.;Park J.-W.;Park J.H.;Po-Chin Liang;Hidaka H.;Izumi N.;Heo J.;Lee Y.J.;Sheen I.-S.;Chiu C.-F.;Arioka H.;Morita S.;Arai Y.; Kudo M.; Cheng A.-L.; Park J.-W.; Park J.H.; PO-CHIN LIANG; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
| 臺大學術典藏 |
2020-04-10T12:51:06Z |
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma
|
Lim H.Y.; Heo J.; Choi H.J.; Lin C.-Y.; Yoon J.-H.; Chiun Hsu; Rau K.-M.; Poon R.T.P.; Yeo W.; Park J.-W.; Tay M.H.; Hsieh W.-S.; Kappeler C.; Rajagopalan P.; Krissel H.; Jeffers M.; Yen C.-J.; Tak W.Y. |
| 臺大學術典藏 |
2019-12-27T07:49:57Z |
GaAs MOSFET using MBE-grown Ga 2 O 3 (Gd 2 O 3 ) as gate oxide
|
Kim, S.-J.; Park, J.-W.; Hong, M.; Mannaerts, J.P.; MINGHWEI HONG |
| 國立成功大學 |
2019 |
First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma
|
Kim, R.D.;Sarker, D.;Meyer, T.;Yau, T.;Macarulla, T.;Park, J.-W.;Choo, S.P.;Hollebecque, A.;Sung, M.W.;Lim, H.-Y.;Mazzaferro, V.;Trojan, J.;Zhu, A.X.;Yoon, J.-H.;Sharma, Sharma S.;Lin, Z.-Z.;Chan, S.L.;Faivre, S.;Feun, L.G.;Yen, C.-J.;Dufour, J.-F.;Palmer, D.H.;Llovet, J.M.;Manoogian, Manoogian M.;Tugnait, M.;Stransky, N.;Hagel, M.;Kohl, N.E.;Lengauer, C.;Sherwin, C.A.;Schmidt-Kittler, O.;Hoeflich, K.P.;Shi, H.;Wolf, B.B.;Kang, Y.-K. |
| 臺大學術典藏 |
2018-09-10T18:04:58Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, M.;Cheng, A.-L.;Park, J.-W.;Park, J.H.;Liang, P.-C.;Hidaka, H.;Izumi, N.;Heo, J.;Lee, Y.J.;Sheen, I.-S.;Chiu, C.-F.;Arioka, H.;Morita, S.;Arai, Y.; PO-CHIN LIANG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T14:52:12Z |
Nanoscale analysis of functionalized polythiophene surfaces: The effects of electropolymerization methods and thermal treatment
|
SHYH-CHYANG LUO;Yu, H.-H.;Park, J.W.;Zhu, B.;Luo, S.-C.;Lee, J.-E.;SHYH-CHYANG LUO; Lee, J.-E.; Luo, S.-C.; Zhu, B.; Park, J.W.; Yu, H.-H.; SHYH-CHYANG LUO |
| 臺大學術典藏 |
2018-09-10T14:52:12Z |
Nanoscale analysis of a functionalized polythiophene surface by adhesion mapping
|
SHYH-CHYANG LUO;Yu, H.-H.;Zhu, B.;Luo, S.-C.;Park, J.W.;Kwak, J.-W.;Lee, J.-E.;SHYH-CHYANG LUO; Lee, J.-E.; Kwak, J.-W.; Park, J.W.; Luo, S.-C.; Zhu, B.; Yu, H.-H.; SHYH-CHYANG LUO |
显示项目 21-30 / 32 (共4页)
<< < 1 2 3 4 > >>
每页显示[10|25|50]项目
|
